This event has passed.
Start time where you are: Your time zone couldn't be detected. Try reloading the page.
Learn how QCI Interpret, clinical decision support software for variant interpretation and reporting, can help your lab rapidly identify pathogenic variants, improve diagnostic yields, and significantly reduce test turnaround time for hereditary diseases. Attendees will receive a demonstration of QCI Interpret’s unique capabilities and advanced features for germline variant interpretation with example workflows for carrier screening and whole-exome sequencing panels. Key highlights will include how your lab can expedite variant interpretation by leveraging the most extensive, manually curated knowledge base, dynamically compute pathogenicity based on ACMG guidelines for every variant with full transparency, and leverage QCI Interpret’s proprietary augmented molecular intelligence approach to literature curation and variant classification to streamline your interpretation workflow.
In this webinar, attendees will:
Speaker:
Elias Hage, PhD, is the Associate Director of Global Product Management for Hereditary Disease and Oncology Applications at QIAGEN Digital Insights (QDI). In this role, he oversees the development, management, and optimization of QDI software, databases and services for genomic analysis and interpretation of hereditary disease and oncology cases. Prior to joining QDI, Dr. Hage served as a Global Product Manager at Agilent Technologies, where he managed the Genomics division flagship SaaS application (Alissa Interpret) and supported its usage globally in both research and IVD settings. Dr. Hage obtained his Ph.D. in virology and genomics from Hannover Medical School in Belgium.
